Global Livestock Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Livestock Vaccine market size is predicted to grow from US$ 371 million in 2025 to US$ 524 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Livestock Vaccine Industry Forecast” looks at past sales and reviews total world Livestock Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Livestock Vaccine sales for 2025 through 2031. With Livestock Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Livestock Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Livestock Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Livestock Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Livestock Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Livestock Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Livestock Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Livestock Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Livestock Vaccine market?
What factors are driving Livestock Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Livestock Vaccine market opportunities vary by end market size?
How does Livestock Vaccine break out by Type, by Application?
The global Livestock Vaccine market size is predicted to grow from US$ 371 million in 2025 to US$ 524 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Livestock Vaccine Industry Forecast” looks at past sales and reviews total world Livestock Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Livestock Vaccine sales for 2025 through 2031. With Livestock Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Livestock Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Livestock Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Livestock Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Livestock Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Livestock Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Livestock Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Livestock Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Livestock
- Poultry
- Farm
- Laboratory
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer HealthCare AG
- Merck Animal Health
- Virbac SA
- Zoetis
- Ceva Sante Animale
- Boehringer Ingelheim
- Vaxxinova®
- Elanco
- MEVAC
- Venky's
- Japfa Comfeed Indonesia
- Nisseiken
- Jinyu Biotechnology
- Harbin Pharmaceutical Group
What is the 10-year outlook for the global Livestock Vaccine market?
What factors are driving Livestock Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Livestock Vaccine market opportunities vary by end market size?
How does Livestock Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Livestock Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Livestock Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Livestock Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Livestock Vaccine Segment by Type
2.2.1 Livestock
2.2.2 Poultry
2.3 Livestock Vaccine Sales by Type
2.3.1 Global Livestock Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Livestock Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Livestock Vaccine Sale Price by Type (2020-2025)
2.4 Livestock Vaccine Segment by Application
2.4.1 Farm
2.4.2 Laboratory
2.5 Livestock Vaccine Sales by Application
2.5.1 Global Livestock Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Livestock Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Livestock Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Livestock Vaccine Breakdown Data by Company
3.1.1 Global Livestock Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Livestock Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Livestock Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Livestock Vaccine Revenue by Company (2020-2025)
3.2.2 Global Livestock Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Livestock Vaccine Sale Price by Company
3.4 Key Manufacturers Livestock Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Livestock Vaccine Product Location Distribution
3.4.2 Players Livestock Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVESTOCK VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Livestock Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Livestock Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Livestock Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Livestock Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Livestock Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Livestock Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Livestock Vaccine Sales Growth
4.4 APAC Livestock Vaccine Sales Growth
4.5 Europe Livestock Vaccine Sales Growth
4.6 Middle East & Africa Livestock Vaccine Sales Growth
5 AMERICAS
5.1 Americas Livestock Vaccine Sales by Country
5.1.1 Americas Livestock Vaccine Sales by Country (2020-2025)
5.1.2 Americas Livestock Vaccine Revenue by Country (2020-2025)
5.2 Americas Livestock Vaccine Sales by Type (2020-2025)
5.3 Americas Livestock Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Livestock Vaccine Sales by Region
6.1.1 APAC Livestock Vaccine Sales by Region (2020-2025)
6.1.2 APAC Livestock Vaccine Revenue by Region (2020-2025)
6.2 APAC Livestock Vaccine Sales by Type (2020-2025)
6.3 APAC Livestock Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Livestock Vaccine by Country
7.1.1 Europe Livestock Vaccine Sales by Country (2020-2025)
7.1.2 Europe Livestock Vaccine Revenue by Country (2020-2025)
7.2 Europe Livestock Vaccine Sales by Type (2020-2025)
7.3 Europe Livestock Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Livestock Vaccine by Country
8.1.1 Middle East & Africa Livestock Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Livestock Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Livestock Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Livestock Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Livestock Vaccine
10.3 Manufacturing Process Analysis of Livestock Vaccine
10.4 Industry Chain Structure of Livestock Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Livestock Vaccine Distributors
11.3 Livestock Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVESTOCK VACCINE BY GEOGRAPHIC REGION
12.1 Global Livestock Vaccine Market Size Forecast by Region
12.1.1 Global Livestock Vaccine Forecast by Region (2026-2031)
12.1.2 Global Livestock Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Livestock Vaccine Forecast by Type (2026-2031)
12.7 Global Livestock Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer HealthCare AG
13.1.1 Bayer HealthCare AG Company Information
13.1.2 Bayer HealthCare AG Livestock Vaccine Product Portfolios and Specifications
13.1.3 Bayer HealthCare AG Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer HealthCare AG Main Business Overview
13.1.5 Bayer HealthCare AG Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Livestock Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Virbac SA
13.3.1 Virbac SA Company Information
13.3.2 Virbac SA Livestock Vaccine Product Portfolios and Specifications
13.3.3 Virbac SA Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Virbac SA Main Business Overview
13.3.5 Virbac SA Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Livestock Vaccine Product Portfolios and Specifications
13.4.3 Zoetis Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Ceva Sante Animale
13.5.1 Ceva Sante Animale Company Information
13.5.2 Ceva Sante Animale Livestock Vaccine Product Portfolios and Specifications
13.5.3 Ceva Sante Animale Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Sante Animale Main Business Overview
13.5.5 Ceva Sante Animale Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Livestock Vaccine Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Vaxxinova®
13.7.1 Vaxxinova® Company Information
13.7.2 Vaxxinova® Livestock Vaccine Product Portfolios and Specifications
13.7.3 Vaxxinova® Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vaxxinova® Main Business Overview
13.7.5 Vaxxinova® Latest Developments
13.8 Elanco
13.8.1 Elanco Company Information
13.8.2 Elanco Livestock Vaccine Product Portfolios and Specifications
13.8.3 Elanco Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Elanco Main Business Overview
13.8.5 Elanco Latest Developments
13.9 MEVAC
13.9.1 MEVAC Company Information
13.9.2 MEVAC Livestock Vaccine Product Portfolios and Specifications
13.9.3 MEVAC Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 MEVAC Main Business Overview
13.9.5 MEVAC Latest Developments
13.10 Venky's
13.10.1 Venky's Company Information
13.10.2 Venky's Livestock Vaccine Product Portfolios and Specifications
13.10.3 Venky's Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Venky's Main Business Overview
13.10.5 Venky's Latest Developments
13.11 Japfa Comfeed Indonesia
13.11.1 Japfa Comfeed Indonesia Company Information
13.11.2 Japfa Comfeed Indonesia Livestock Vaccine Product Portfolios and Specifications
13.11.3 Japfa Comfeed Indonesia Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Japfa Comfeed Indonesia Main Business Overview
13.11.5 Japfa Comfeed Indonesia Latest Developments
13.12 Nisseiken
13.12.1 Nisseiken Company Information
13.12.2 Nisseiken Livestock Vaccine Product Portfolios and Specifications
13.12.3 Nisseiken Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Nisseiken Main Business Overview
13.12.5 Nisseiken Latest Developments
13.13 Jinyu Biotechnology
13.13.1 Jinyu Biotechnology Company Information
13.13.2 Jinyu Biotechnology Livestock Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Biotechnology Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Biotechnology Main Business Overview
13.13.5 Jinyu Biotechnology Latest Developments
13.14 Harbin Pharmaceutical Group
13.14.1 Harbin Pharmaceutical Group Company Information
13.14.2 Harbin Pharmaceutical Group Livestock Vaccine Product Portfolios and Specifications
13.14.3 Harbin Pharmaceutical Group Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Harbin Pharmaceutical Group Main Business Overview
13.14.5 Harbin Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Livestock Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Livestock Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Livestock
Table 4. Major Players of Poultry
Table 5. Global Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 6. Global Livestock Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Livestock Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Livestock Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Livestock Vaccine Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Livestock Vaccine Sale by Application (2020-2025) & (MT)
Table 11. Global Livestock Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Livestock Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Livestock Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Livestock Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Livestock Vaccine Sales by Company (2020-2025) & (MT)
Table 16. Global Livestock Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Livestock Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Livestock Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Livestock Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Livestock Vaccine Producing Area Distribution and Sales Area
Table 21. Players Livestock Vaccine Products Offered
Table 22. Livestock Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Livestock Vaccine Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Livestock Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Livestock Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Livestock Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Livestock Vaccine Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Livestock Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Livestock Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Livestock Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 34. Americas Livestock Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Livestock Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 37. Americas Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 38. APAC Livestock Vaccine Sales by Region (2020-2025) & (MT)
Table 39. APAC Livestock Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Livestock Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 42. APAC Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 43. Europe Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 44. Europe Livestock Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 46. Europe Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Livestock Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Livestock Vaccine
Table 52. Key Market Challenges & Risks of Livestock Vaccine
Table 53. Key IndustryTrends of Livestock Vaccine
Table 54. Livestock Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Livestock Vaccine Distributors List
Table 57. Livestock Vaccine Customer List
Table 58. Global Livestock Vaccine SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Livestock Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Livestock Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Livestock Vaccine SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Livestock Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Livestock Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Livestock Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Livestock Vaccine SalesForecast byType (2026-2031) & (MT)
Table 69. Global Livestock Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Livestock Vaccine SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Livestock Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Bayer HealthCare AG Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer HealthCare AG Livestock Vaccine Product Portfolios and Specifications
Table 74. Bayer HealthCare AG Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Bayer HealthCare AG Main Business
Table 76. Bayer HealthCare AG Latest Developments
Table 77. Merck Animal Health Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Livestock Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Virbac SA Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Virbac SA Livestock Vaccine Product Portfolios and Specifications
Table 84. Virbac SA Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Virbac SA Main Business
Table 86. Virbac SA Latest Developments
Table 87. Zoetis Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoetis Livestock Vaccine Product Portfolios and Specifications
Table 89. Zoetis Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Zoetis Main Business
Table 91. Zoetis Latest Developments
Table 92. Ceva Sante Animale Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva Sante Animale Livestock Vaccine Product Portfolios and Specifications
Table 94. Ceva Sante Animale Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Ceva Sante Animale Main Business
Table 96. Ceva Sante Animale Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Livestock Vaccine Product Portfolios and Specifications
Table 99. Boehringer Ingelheim Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
Table 102. Vaxxinova® Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Vaxxinova® Livestock Vaccine Product Portfolios and Specifications
Table 104. Vaxxinova® Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Vaxxinova® Main Business
Table 106. Vaxxinova® Latest Developments
Table 107. Elanco Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Elanco Livestock Vaccine Product Portfolios and Specifications
Table 109. Elanco Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Elanco Main Business
Table 111. Elanco Latest Developments
Table 112. MEVAC Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. MEVAC Livestock Vaccine Product Portfolios and Specifications
Table 114. MEVAC Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. MEVAC Main Business
Table 116. MEVAC Latest Developments
Table 117. Venky's Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Venky's Livestock Vaccine Product Portfolios and Specifications
Table 119. Venky's Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Venky's Main Business
Table 121. Venky's Latest Developments
Table 122. Japfa Comfeed Indonesia Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Japfa Comfeed Indonesia Livestock Vaccine Product Portfolios and Specifications
Table 124. Japfa Comfeed Indonesia Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Japfa Comfeed Indonesia Main Business
Table 126. Japfa Comfeed Indonesia Latest Developments
Table 127. Nisseiken Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Nisseiken Livestock Vaccine Product Portfolios and Specifications
Table 129. Nisseiken Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. Nisseiken Main Business
Table 131. Nisseiken Latest Developments
Table 132. Jinyu Biotechnology Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Jinyu Biotechnology Livestock Vaccine Product Portfolios and Specifications
Table 134. Jinyu Biotechnology Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. Jinyu Biotechnology Main Business
Table 136. Jinyu Biotechnology Latest Developments
Table 137. Harbin Pharmaceutical Group Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Harbin Pharmaceutical Group Livestock Vaccine Product Portfolios and Specifications
Table 139. Harbin Pharmaceutical Group Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 140. Harbin Pharmaceutical Group Main Business
Table 141. Harbin Pharmaceutical Group Latest Developments
LIST OFFIGURES
Figure 1. Picture of Livestock Vaccine
Figure 2. Livestock Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Livestock Vaccine Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Livestock Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Livestock Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Livestock Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Livestock Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Livestock
Figure 12. Product Picture of Poultry
Figure 13. Global Livestock Vaccine Sales Market Share byType in 2025
Figure 14. Global Livestock Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Livestock Vaccine Consumed inFarm
Figure 16. Global Livestock Vaccine Market:Farm (2020-2025) & (MT)
Figure 17. Livestock Vaccine Consumed in Laboratory
Figure 18. Global Livestock Vaccine Market: Laboratory (2020-2025) & (MT)
Figure 19. Global Livestock Vaccine Sale Market Share by Application (2024)
Figure 20. Global Livestock Vaccine Revenue Market Share by Application in 2025
Figure 21. Livestock Vaccine Sales by Company in 2025 (MT)
Figure 22. Global Livestock Vaccine Sales Market Share by Company in 2025
Figure 23. Livestock Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Livestock Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Livestock Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Livestock Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Livestock Vaccine Sales 2020-2025 (MT)
Figure 28. Americas Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Livestock Vaccine Sales 2020-2025 (MT)
Figure 30. APAC Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Livestock Vaccine Sales 2020-2025 (MT)
Figure 32. Europe Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Livestock Vaccine Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Livestock Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Livestock Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Livestock Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Livestock Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Livestock Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Livestock Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Livestock Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Livestock Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Livestock Vaccine
Figure 73. Industry Chain Structure of Livestock Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Livestock Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Livestock Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Livestock Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Livestock Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Livestock Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Livestock Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Livestock Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Livestock Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Livestock Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Livestock Vaccine Segment by Type
2.2.1 Livestock
2.2.2 Poultry
2.3 Livestock Vaccine Sales by Type
2.3.1 Global Livestock Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Livestock Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Livestock Vaccine Sale Price by Type (2020-2025)
2.4 Livestock Vaccine Segment by Application
2.4.1 Farm
2.4.2 Laboratory
2.5 Livestock Vaccine Sales by Application
2.5.1 Global Livestock Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Livestock Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Livestock Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Livestock Vaccine Breakdown Data by Company
3.1.1 Global Livestock Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Livestock Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Livestock Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Livestock Vaccine Revenue by Company (2020-2025)
3.2.2 Global Livestock Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Livestock Vaccine Sale Price by Company
3.4 Key Manufacturers Livestock Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Livestock Vaccine Product Location Distribution
3.4.2 Players Livestock Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVESTOCK VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Livestock Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Livestock Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Livestock Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Livestock Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Livestock Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Livestock Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Livestock Vaccine Sales Growth
4.4 APAC Livestock Vaccine Sales Growth
4.5 Europe Livestock Vaccine Sales Growth
4.6 Middle East & Africa Livestock Vaccine Sales Growth
5 AMERICAS
5.1 Americas Livestock Vaccine Sales by Country
5.1.1 Americas Livestock Vaccine Sales by Country (2020-2025)
5.1.2 Americas Livestock Vaccine Revenue by Country (2020-2025)
5.2 Americas Livestock Vaccine Sales by Type (2020-2025)
5.3 Americas Livestock Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Livestock Vaccine Sales by Region
6.1.1 APAC Livestock Vaccine Sales by Region (2020-2025)
6.1.2 APAC Livestock Vaccine Revenue by Region (2020-2025)
6.2 APAC Livestock Vaccine Sales by Type (2020-2025)
6.3 APAC Livestock Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Livestock Vaccine by Country
7.1.1 Europe Livestock Vaccine Sales by Country (2020-2025)
7.1.2 Europe Livestock Vaccine Revenue by Country (2020-2025)
7.2 Europe Livestock Vaccine Sales by Type (2020-2025)
7.3 Europe Livestock Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Livestock Vaccine by Country
8.1.1 Middle East & Africa Livestock Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Livestock Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Livestock Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Livestock Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Livestock Vaccine
10.3 Manufacturing Process Analysis of Livestock Vaccine
10.4 Industry Chain Structure of Livestock Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Livestock Vaccine Distributors
11.3 Livestock Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVESTOCK VACCINE BY GEOGRAPHIC REGION
12.1 Global Livestock Vaccine Market Size Forecast by Region
12.1.1 Global Livestock Vaccine Forecast by Region (2026-2031)
12.1.2 Global Livestock Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Livestock Vaccine Forecast by Type (2026-2031)
12.7 Global Livestock Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer HealthCare AG
13.1.1 Bayer HealthCare AG Company Information
13.1.2 Bayer HealthCare AG Livestock Vaccine Product Portfolios and Specifications
13.1.3 Bayer HealthCare AG Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer HealthCare AG Main Business Overview
13.1.5 Bayer HealthCare AG Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Livestock Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Virbac SA
13.3.1 Virbac SA Company Information
13.3.2 Virbac SA Livestock Vaccine Product Portfolios and Specifications
13.3.3 Virbac SA Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Virbac SA Main Business Overview
13.3.5 Virbac SA Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Livestock Vaccine Product Portfolios and Specifications
13.4.3 Zoetis Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Ceva Sante Animale
13.5.1 Ceva Sante Animale Company Information
13.5.2 Ceva Sante Animale Livestock Vaccine Product Portfolios and Specifications
13.5.3 Ceva Sante Animale Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Sante Animale Main Business Overview
13.5.5 Ceva Sante Animale Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Livestock Vaccine Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Vaxxinova®
13.7.1 Vaxxinova® Company Information
13.7.2 Vaxxinova® Livestock Vaccine Product Portfolios and Specifications
13.7.3 Vaxxinova® Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vaxxinova® Main Business Overview
13.7.5 Vaxxinova® Latest Developments
13.8 Elanco
13.8.1 Elanco Company Information
13.8.2 Elanco Livestock Vaccine Product Portfolios and Specifications
13.8.3 Elanco Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Elanco Main Business Overview
13.8.5 Elanco Latest Developments
13.9 MEVAC
13.9.1 MEVAC Company Information
13.9.2 MEVAC Livestock Vaccine Product Portfolios and Specifications
13.9.3 MEVAC Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 MEVAC Main Business Overview
13.9.5 MEVAC Latest Developments
13.10 Venky's
13.10.1 Venky's Company Information
13.10.2 Venky's Livestock Vaccine Product Portfolios and Specifications
13.10.3 Venky's Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Venky's Main Business Overview
13.10.5 Venky's Latest Developments
13.11 Japfa Comfeed Indonesia
13.11.1 Japfa Comfeed Indonesia Company Information
13.11.2 Japfa Comfeed Indonesia Livestock Vaccine Product Portfolios and Specifications
13.11.3 Japfa Comfeed Indonesia Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Japfa Comfeed Indonesia Main Business Overview
13.11.5 Japfa Comfeed Indonesia Latest Developments
13.12 Nisseiken
13.12.1 Nisseiken Company Information
13.12.2 Nisseiken Livestock Vaccine Product Portfolios and Specifications
13.12.3 Nisseiken Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Nisseiken Main Business Overview
13.12.5 Nisseiken Latest Developments
13.13 Jinyu Biotechnology
13.13.1 Jinyu Biotechnology Company Information
13.13.2 Jinyu Biotechnology Livestock Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Biotechnology Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Biotechnology Main Business Overview
13.13.5 Jinyu Biotechnology Latest Developments
13.14 Harbin Pharmaceutical Group
13.14.1 Harbin Pharmaceutical Group Company Information
13.14.2 Harbin Pharmaceutical Group Livestock Vaccine Product Portfolios and Specifications
13.14.3 Harbin Pharmaceutical Group Livestock Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Harbin Pharmaceutical Group Main Business Overview
13.14.5 Harbin Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Livestock Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Livestock Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Livestock
Table 4. Major Players of Poultry
Table 5. Global Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 6. Global Livestock Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Livestock Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Livestock Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Livestock Vaccine Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Livestock Vaccine Sale by Application (2020-2025) & (MT)
Table 11. Global Livestock Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Livestock Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Livestock Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Livestock Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Livestock Vaccine Sales by Company (2020-2025) & (MT)
Table 16. Global Livestock Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Livestock Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Livestock Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Livestock Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Livestock Vaccine Producing Area Distribution and Sales Area
Table 21. Players Livestock Vaccine Products Offered
Table 22. Livestock Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Livestock Vaccine Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Livestock Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Livestock Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Livestock Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Livestock Vaccine Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Livestock Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Livestock Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Livestock Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 34. Americas Livestock Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Livestock Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 37. Americas Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 38. APAC Livestock Vaccine Sales by Region (2020-2025) & (MT)
Table 39. APAC Livestock Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Livestock Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 42. APAC Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 43. Europe Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 44. Europe Livestock Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 46. Europe Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Livestock Vaccine Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Livestock Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Livestock Vaccine Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Livestock Vaccine Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Livestock Vaccine
Table 52. Key Market Challenges & Risks of Livestock Vaccine
Table 53. Key IndustryTrends of Livestock Vaccine
Table 54. Livestock Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Livestock Vaccine Distributors List
Table 57. Livestock Vaccine Customer List
Table 58. Global Livestock Vaccine SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Livestock Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Livestock Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Livestock Vaccine SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Livestock Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Livestock Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Livestock Vaccine SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Livestock Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Livestock Vaccine SalesForecast byType (2026-2031) & (MT)
Table 69. Global Livestock Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Livestock Vaccine SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Livestock Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Bayer HealthCare AG Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer HealthCare AG Livestock Vaccine Product Portfolios and Specifications
Table 74. Bayer HealthCare AG Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Bayer HealthCare AG Main Business
Table 76. Bayer HealthCare AG Latest Developments
Table 77. Merck Animal Health Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Livestock Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Virbac SA Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Virbac SA Livestock Vaccine Product Portfolios and Specifications
Table 84. Virbac SA Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Virbac SA Main Business
Table 86. Virbac SA Latest Developments
Table 87. Zoetis Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoetis Livestock Vaccine Product Portfolios and Specifications
Table 89. Zoetis Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Zoetis Main Business
Table 91. Zoetis Latest Developments
Table 92. Ceva Sante Animale Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva Sante Animale Livestock Vaccine Product Portfolios and Specifications
Table 94. Ceva Sante Animale Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Ceva Sante Animale Main Business
Table 96. Ceva Sante Animale Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Livestock Vaccine Product Portfolios and Specifications
Table 99. Boehringer Ingelheim Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
Table 102. Vaxxinova® Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Vaxxinova® Livestock Vaccine Product Portfolios and Specifications
Table 104. Vaxxinova® Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Vaxxinova® Main Business
Table 106. Vaxxinova® Latest Developments
Table 107. Elanco Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Elanco Livestock Vaccine Product Portfolios and Specifications
Table 109. Elanco Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Elanco Main Business
Table 111. Elanco Latest Developments
Table 112. MEVAC Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. MEVAC Livestock Vaccine Product Portfolios and Specifications
Table 114. MEVAC Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. MEVAC Main Business
Table 116. MEVAC Latest Developments
Table 117. Venky's Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Venky's Livestock Vaccine Product Portfolios and Specifications
Table 119. Venky's Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Venky's Main Business
Table 121. Venky's Latest Developments
Table 122. Japfa Comfeed Indonesia Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Japfa Comfeed Indonesia Livestock Vaccine Product Portfolios and Specifications
Table 124. Japfa Comfeed Indonesia Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Japfa Comfeed Indonesia Main Business
Table 126. Japfa Comfeed Indonesia Latest Developments
Table 127. Nisseiken Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Nisseiken Livestock Vaccine Product Portfolios and Specifications
Table 129. Nisseiken Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. Nisseiken Main Business
Table 131. Nisseiken Latest Developments
Table 132. Jinyu Biotechnology Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Jinyu Biotechnology Livestock Vaccine Product Portfolios and Specifications
Table 134. Jinyu Biotechnology Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. Jinyu Biotechnology Main Business
Table 136. Jinyu Biotechnology Latest Developments
Table 137. Harbin Pharmaceutical Group Basic Information, Livestock Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Harbin Pharmaceutical Group Livestock Vaccine Product Portfolios and Specifications
Table 139. Harbin Pharmaceutical Group Livestock Vaccine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 140. Harbin Pharmaceutical Group Main Business
Table 141. Harbin Pharmaceutical Group Latest Developments
LIST OFFIGURES
Figure 1. Picture of Livestock Vaccine
Figure 2. Livestock Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Livestock Vaccine Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Livestock Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Livestock Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Livestock Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Livestock Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Livestock
Figure 12. Product Picture of Poultry
Figure 13. Global Livestock Vaccine Sales Market Share byType in 2025
Figure 14. Global Livestock Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Livestock Vaccine Consumed inFarm
Figure 16. Global Livestock Vaccine Market:Farm (2020-2025) & (MT)
Figure 17. Livestock Vaccine Consumed in Laboratory
Figure 18. Global Livestock Vaccine Market: Laboratory (2020-2025) & (MT)
Figure 19. Global Livestock Vaccine Sale Market Share by Application (2024)
Figure 20. Global Livestock Vaccine Revenue Market Share by Application in 2025
Figure 21. Livestock Vaccine Sales by Company in 2025 (MT)
Figure 22. Global Livestock Vaccine Sales Market Share by Company in 2025
Figure 23. Livestock Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Livestock Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Livestock Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Livestock Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Livestock Vaccine Sales 2020-2025 (MT)
Figure 28. Americas Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Livestock Vaccine Sales 2020-2025 (MT)
Figure 30. APAC Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Livestock Vaccine Sales 2020-2025 (MT)
Figure 32. Europe Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Livestock Vaccine Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Livestock Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Livestock Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Livestock Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Livestock Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Livestock Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Livestock Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Livestock Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Livestock Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Livestock Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Livestock Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Livestock Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Livestock Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Livestock Vaccine
Figure 73. Industry Chain Structure of Livestock Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Livestock Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Livestock Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Livestock Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Livestock Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Livestock Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Livestock Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Fluphenazine Decanoate Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
90 pages
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
109 pages
Global In Vitro Protein Expression Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
114 pages
Global Medical Hydrophilic Coating Market Growth 2025-2031
US$ 3,660.00
April 2025
139 pages
Global Mesalazine Market Growth 2025-2031
US$ 3,660.00
January 2025
120 pages
